Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06971250) titled 'Peripheral KV7 Activation for Pain Relief' on May 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Stefan Heber
Condition:
Pain
Intervention:
Drug: Capsaicin only (7.6 ng)
Drug: Capsaicin + Flupirtine 0.5 µg
Drug: Capsaicin + Flupirtine 1.2 µg
Drug: Capsaicin + Flupirtine 3.0 µg
Drug: Capsaicin + Flupirtine 7.6 µg
Drug: Placebo (SIF only, no capsaicin or Flupirtine)
Drug: Room Temperature Injection (Control)
Drug: Heated ...